Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Prasad Rao Kopparapu"'
Autor:
Edmond F O'Donnell, Prasad Rao Kopparapu, Daniel C Koch, Hyo Sang Jang, Jessica Lynne Phillips, Robert L Tanguay, Nancy I Kerkvliet, Siva Kumar Kolluri
Publikováno v:
PLoS ONE, Vol 7, Iss 7, p e40926 (2012)
A novel role of the dihydroorotatedehydrogenase (DHODH) inhibitor leflunomide as a potential anti-melanoma therapy was recently reported (Nature 471:518-22, 2011). We previously reported that leflunomide strongly activates the transcriptional activit
Externí odkaz:
https://doaj.org/article/ca4c067be86c4cbb82572b155e28740e
Autor:
Hyo Sang Jang, John T. Gamble, Prasad Rao Kopparapu, Martin C. Pearce, Robert L. Tanguay, Juliet A. Greenwood, Siva Kumar Kolluri
Publikováno v:
Cancer Research. 78:P3-06
While potential therapies might have pronounced success in the simplified settings in cell culture medium, many drugs fail or underperform when cancer cells are encased in a complex 3D microenvironment. Although, rat and mouse models will continue to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3643e010459509e2addbac021747f0b
https://doi.org/10.1158/1538-7445.sabcs17-p3-06-04
https://doi.org/10.1158/1538-7445.sabcs17-p3-06-04
Autor:
Roberta L. Tanguay, John T. Gamble, Martin C. Pearce, Arnold C. Satterthwait, Prasad Rao Kopparapu, Edmond F. O’Donnell, Julie A. Greenwood, Hyo Sang Jang, Siva Kumar Kolluri, Xiao-kun Zhang, Monica J. Mueller
Publikováno v:
Oncotarget
// Martin C. Pearce 1 , John T. Gamble 1, 2 , Prasad R. Kopparapu 1 , Edmond F. O'Donnell 1 , Monica J. Mueller 1 , Hyo Sang Jang 1 , Julie A. Greenwood 2 , Arnold C. Satterthwait 3 , Robert L. Tanguay 4, 5, 6 , Xiao-Kun Zhang 3 and Siva Kumar Kollur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6aa6dfbbd2b309bc0b5ab599764b5208
https://pubmed.ncbi.nlm.nih.gov/29899843
https://pubmed.ncbi.nlm.nih.gov/29899843
Autor:
Hyo Sang Jang, Sumit Punj, Siva Kumar Kolluri, Edmond F. O’Donnell, Nancy I. Kerkvliet, Prasad Rao Kopparapu, William H. Bisson, Daniel C. Koch
Publikováno v:
Oncogene. 34(50)
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor and a member of the basic helix-loop-helix PER/ARNT/SIM family of chemosensors and developmental regulators. The AhR is widely known as a mediator of dioxin toxicity; howe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c5dfc17293ee67c418ddd6b8506e904
https://pubmed.ncbi.nlm.nih.gov/25867062
https://pubmed.ncbi.nlm.nih.gov/25867062
Autor:
Siva Kumar Kolluri, Hyo Sang Jang, Jamie M. Pennington, Sumit Punj, Patrick L. Iversen, Diana Rohlman, Jessica Lynne Phillips, Prasad Rao Kopparapu, Edmond F. O’Donnell, Nancy I. Kerkvliet
Publikováno v:
PLoS ONE, Vol 9, Iss 2, p e88726 (2014)
PLoS ONE
PLoS ONE
The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that plays multiple roles in regulation of immune and inflammatory responses. The ability of certain AhR ligands to induce regulatory T cells (Tregs) has generated interes
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24d7100f51359d2bccfd33f143f092ff
http://europepmc.org/articles/PMC3929365?pdf=render
http://europepmc.org/articles/PMC3929365?pdf=render
Autor:
Nancy I. Kerkvliet, Edmond F. O’Donnell, Prasad Rao Kopparapu, Hyo Sang Jang, Robert L. Tanguay, Siva Kumar Kolluri, Daniel C. Koch, Jessica Lynne Phillips
Publikováno v:
PLoS ONE
PLoS ONE, Vol 7, Iss 7, p e40926 (2012)
PLoS ONE, Vol 7, Iss 7, p e40926 (2012)
A novel role of the dihydroorotatedehydrogenase (DHODH) inhibitor leflunomide as a potential anti-melanoma therapy was recently reported (Nature 471:518-22, 2011). We previously reported that leflunomide strongly activates the transcriptional activit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51f4a91d6b071819a514dcdc74e73dba
https://pubmed.ncbi.nlm.nih.gov/22815870
https://pubmed.ncbi.nlm.nih.gov/22815870
Autor:
Lijoy K. Mathew, Katerine S. Saili, Robert L. Tanguay, Prasad Rao Kopparapu, Daniel C. Koch, David G. Farrer, Siva Kumar Kolluri, Edmond F. O’Donnell, William H. Bisson, Sumitra Sengupta, Nancy I. Kerkvliet
Publikováno v:
PLoS ONE, Vol 5, Iss 10 (2010)
PLoS ONE
PLoS ONE
Background The aryl hydrocarbon receptor (AhR) is a ligand-activated transcription factor that mediates the toxicity and biological activity of dioxins and related chemicals. The AhR influences a variety of processes involved in cellular growth and d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2a7a71eb65e84a0b9097f8c34856eee
https://doi.org/10.1371/journal.pone.0013128
https://doi.org/10.1371/journal.pone.0013128